397 related articles for article (PubMed ID: 12404514)
1. Modeling Alzheimer's disease immune therapy mechanisms: interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide.
Lue LF; Walker DG
J Neurosci Res; 2002 Nov; 70(4):599-610. PubMed ID: 12404514
[TBL] [Abstract][Full Text] [Related]
2. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.
Lue LF; Walker DG; Brachova L; Beach TG; Rogers J; Schmidt AM; Stern DM; Yan SD
Exp Neurol; 2001 Sep; 171(1):29-45. PubMed ID: 11520119
[TBL] [Abstract][Full Text] [Related]
3. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
[TBL] [Abstract][Full Text] [Related]
4. CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide.
Townsend KP; Town T; Mori T; Lue LF; Shytle D; Sanberg PR; Morgan D; Fernandez F; Flavell RA; Tan J
Eur J Immunol; 2005 Mar; 35(3):901-10. PubMed ID: 15688347
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy for Alzheimer's disease.
McGeer PL; McGeer E
Sci Aging Knowledge Environ; 2004 Jul; 2004(27):pe29. PubMed ID: 15243154
[TBL] [Abstract][Full Text] [Related]
6. Nonviral DNA vaccination augments microglial phagocytosis of beta-amyloid deposits as a major clearance pathway in an Alzheimer disease mouse model.
Okura Y; Kohyama K; Park IK; Matsumoto Y
J Neuropathol Exp Neurol; 2008 Nov; 67(11):1063-71. PubMed ID: 18957895
[TBL] [Abstract][Full Text] [Related]
7. LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide.
Liu Y; Walter S; Stagi M; Cherny D; Letiembre M; Schulz-Schaeffer W; Heine H; Penke B; Neumann H; Fassbender K
Brain; 2005 Aug; 128(Pt 8):1778-89. PubMed ID: 15857927
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.
Geylis V; Steinitz M
Autoimmun Rev; 2006 Jan; 5(1):33-9. PubMed ID: 16338209
[TBL] [Abstract][Full Text] [Related]
9. Complement component C1q modulates the phagocytosis of Abeta by microglia.
Webster SD; Yang AJ; Margol L; Garzon-Rodriguez W; Glabe CG; Tenner AJ
Exp Neurol; 2000 Jan; 161(1):127-38. PubMed ID: 10683279
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications.
El Khoury J; Luster AD
Trends Pharmacol Sci; 2008 Dec; 29(12):626-32. PubMed ID: 18835047
[TBL] [Abstract][Full Text] [Related]
11. Minocycline does not affect amyloid beta phagocytosis by human microglial cells.
Familian A; Eikelenboom P; Veerhuis R
Neurosci Lett; 2007 Apr; 416(1):87-91. PubMed ID: 17317005
[TBL] [Abstract][Full Text] [Related]
12. Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease.
Cui Y; Le Y; Yazawa H; Gong W; Wang JM
J Leukoc Biol; 2002 Oct; 72(4):628-35. PubMed ID: 12377930
[TBL] [Abstract][Full Text] [Related]
13. Possible role of scavenger receptor SRCL in the clearance of amyloid-beta in Alzheimer's disease.
Nakamura K; Ohya W; Funakoshi H; Sakaguchi G; Kato A; Takeda M; Kudo T; Nakamura T
J Neurosci Res; 2006 Sep; 84(4):874-90. PubMed ID: 16868960
[TBL] [Abstract][Full Text] [Related]
14. Humoral immune response to fibrillar beta-amyloid peptide.
Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
[TBL] [Abstract][Full Text] [Related]
15. Amyloid-beta up-regulates complement factor B in retinal pigment epithelial cells through cytokines released from recruited macrophages/microglia: Another mechanism of complement activation in age-related macular degeneration.
Wang J; Ohno-Matsui K; Yoshida T; Shimada N; Ichinose S; Sato T; Mochizuki M; Morita I
J Cell Physiol; 2009 Jul; 220(1):119-28. PubMed ID: 19277984
[TBL] [Abstract][Full Text] [Related]
16. Microglia as a potential bridge between the amyloid beta-peptide and tau.
Kitazawa M; Yamasaki TR; LaFerla FM
Ann N Y Acad Sci; 2004 Dec; 1035():85-103. PubMed ID: 15681802
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin and Alzheimer's disease immunotherapy.
Solomon B
Curr Opin Mol Ther; 2007 Feb; 9(1):79-85. PubMed ID: 17330405
[TBL] [Abstract][Full Text] [Related]
18. Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology.
Bard F; Barbour R; Cannon C; Carretto R; Fox M; Games D; Guido T; Hoenow K; Hu K; Johnson-Wood K; Khan K; Kholodenko D; Lee C; Lee M; Motter R; Nguyen M; Reed A; Schenk D; Tang P; Vasquez N; Seubert P; Yednock T
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2023-8. PubMed ID: 12566568
[TBL] [Abstract][Full Text] [Related]
19. Bip/GRP78-induced production of cytokines and uptake of amyloid-beta(1-42) peptide in microglia.
Kakimura J; Kitamura Y; Taniguchi T; Shimohama S; Gebicke-Haerter PJ
Biochem Biophys Res Commun; 2001 Feb; 281(1):6-10. PubMed ID: 11178952
[TBL] [Abstract][Full Text] [Related]
20. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
